Vaccination of dairy calves with bovine adenovirus type 3.
A field study was undertaken to determine the efficacy of vaccinating dairy calves with a killed bovine adenovirus type 3 (BA3) vaccine in a herd where pneumonia associated with BA3 infection had been a severe problem. Calves were first vaccinated when they were less than one week old; a second dose was given 10-14 days later. Efficacy of the vaccine was evaluated following natural exposure to the virus by comparing prevalence of pneumonia in control (n = 21) and vaccinated (n = 21) calves. Seroconversion to BA3 was shown in 9 of 12 control calves that developed pneumonia, 4 of these calves subsequently died as a result of the disease. Four additional control calves had a subclinical infection with the virus. All calves in the vaccinated group developed virus-neutralizing antibodies which averaged 1:20 eight weeks after the second vaccination. The serologic response to vaccination was not inhibited in calves possessing low levels of colostral antibodies. Two vaccinated calves developed pneumonia but they did not succumb to the disease. The prevalence of pneumonia in vaccinated calves was significantly reduced (P less than 0.05) when compared to control calves.